12.11
12-March-25 15:45:01
15 minutes delayed
Stocks
+0.67
+5.86%
Today's range
11.47 - 12.38
ISIN
N/A
Source
NASDAQ
Replimune to Present at the 39th Annual J.P. Morgan Healthcare Conference
06 Jan 2021 07:00:01 By Nasdaq GlobeNewswire
Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with Advanced Solid Tumors
05 Jan 2021 07:00:02 By Nasdaq GlobeNewswire